Diabetes Treatment Devices Market to Reach US$ 16,706.4 Mn
Medtronic reports full year and fourth quarter fiscal year 2022 financial results; announces 8% dividend increase - May 26, 2022
Medtronic Puts Woes in Past With Soaring Sales in Diabetes Unit - Bloomberg
Medtronic: The world's largest medical device company is an excellent re-opening play | FSMOne
Medtronic snaps up EOFlow for $738 million to bolster its diabetes business
Dividend Aristocrats In Focus: Medtronic
Gewinn & Umsatz News zur MEDTRONIC Aktie :: IE00BTN1Y115 | A14M2J | FRA:2M6 | ETR:2M6
Diabetes Growth Key To Hitting Medtronic's Longer-Term Targets (NYSE:MDT) | Seeking Alpha
Medtronic Puts Woes in Past With Soaring Sales in Diabetes Unit - Bloomberg
Medtronic Revenue Boosted by Covidien Acquisition - WSJ
Medtronic reports first quarter fiscal 2023 financial results - Aug 23, 2022
Medtronic (MDT): Diabetes Group Expected to Become a Larger Driver of Revenue Growth - Visible Alpha
Medtronic reports full year and fourth quarter fiscal 2023 financial results; announces dividend increase - May 25, 2023
Medtronic shares stand firm following earnings beat
Medtronic Stock: Weakness In Diabetes Segment Can Push Shares Lower (NYSE:MDT) | Seeking Alpha
Medtronic plays catch-up in diabetes | Evaluate
MiniMed infusion sets: Medtronic recalls 5,000 MiniMed infusion sets from India - The Economic Times
The Downside of Early FDA Approval | mddionline.com
Medtronic - Wikipedia
Medtronic significantly extends time in range with Minimed 780G | BioWorld
Investor Eavesdropping: Diabetes Tech Updates in Early 2017
Medtronic Reports Second Quarter Fiscal 2022 Financial Results - Nov 23, 2021
Medtronic reports full year and fourth quarter fiscal year 2022 financial results; announces 8% dividend increase - May 26, 2022
